We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+19.36%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$95.4M
AUM Growth
+$5.28M
(+5.9%)
Cap. Flow
-$3.93M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
38.61%
Holding
118
New
12
Increased
17
Reduced
46
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vericel Corp
VCEL
|
+$1.17M |
| 2 |
ATRS
Antares Pharma, Inc.
ATRS
|
+$1.1M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.02M |
| 4 |
ATHX
Athersys, Inc. Common Stock
ATHX
|
+$556K |
| 5 |
Veracyte
VCYT
|
+$506K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CryoPort
CYRX
|
+$1.36M |
| 2 |
JetBlue
JBLU
|
+$1.05M |
| 3 |
AtriCure
ATRC
|
+$959K |
| 4 |
NCR Voyix
VYX
|
+$854K |
| 5 |
SNAK
Inventure Foods, Inc.
SNAK
|
+$705K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 63.84% |
| 2 | Technology | 9.27% |
| 3 | Industrials | 8.69% |
| 4 | Communication Services | 3.79% |
| 5 | Financials | 2.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VG
51
DELISTED
Vonage Holdings Corporation
VG
| $565K | 0.59% |
69,450
| – | – |
|
|
HDP
52
DELISTED
Hortonworks, Inc.
HDP
| $551K | 0.58% |
32,525
-150
| -0.5% | -$2.26K |
|
|
53
Veracyte
VCYT
$4.45B
| $546K | 0.57% |
+62,275
| New | +$506K |
|
54
3M
MMM
$93.7B
| $541K | 0.57% |
3,081
| – | – |
|
55
Verizon
VZ
$202B
| $540K | 0.57% |
10,917
-263
| -2% | -$12.4K |
|
56
Kimberly-Clark
KMB
$37.7B
| $524K | 0.55% |
4,450
| – | – |
|
|
TBCH
57
Turtle Beach Corp
TBCH
$257M
| $520K | 0.54% |
156,590
+25,015
| +19% | +$73.1K |
|
58
CareDx
CDNA
$1.84B
| $513K | 0.54% |
+138,550
| New | +$291K |
|
|
BEAT
59
DELISTED
BioTelemetry, Inc.
BEAT
| $495K | 0.52% |
15,000
| – | – |
|
60
GSK
GSK
$108B
| $483K | 0.51% |
9,520
| – | – |
|
61
Xtant Medical Holdings
XTNT
$57.7M
| $455K | 0.48% |
52,592
-333
| -0.6% | -$2.98K |
|
62
CarParts.com
PRTS
$42.8M
| $438K | 0.46% |
15,170
-2,090
| -12% | -$59.8K |
|
|
OPGN
63
DELISTED
OpGen, Inc
OPGN
| $434K | 0.45% |
+14
| New | +$449K |
|
|
CY
64
DELISTED
Cypress Semiconductor
CY
| $430K | 0.45% |
28,625
+750
| +3% | +$10.5K |
|
65
Ionis Pharmaceuticals
IONS
$8.96B
| $418K | 0.44% |
8,250
+300
| +4% | +$15.7K |
|
|
ASRT
66
DELISTED
Assertio
ASRT
| $415K | 0.43% |
1,196
-94
| -7% | -$44.3K |
|
67
US Bancorp
USB
$99.7B
| $411K | 0.43% |
7,662
| – | – |
|
68
Micron Technology
MU
$922B
| $393K | 0.41% |
10,000
-1,000
| -9% | -$31.6K |
|
|
SRCI
69
DELISTED
SRC Energy Inc
SRCI
| $387K | 0.41% |
40,000
| – | – |
|
70
LifeVantage
LFVN
$80.5M
| $343K | 0.36% |
81,225
| – | – |
|
71
Plus Therapeutics
PSTV
$25.8M
| $335K | 0.35% |
5
| – | – |
|
|
TEAR
72
DELISTED
TearLab Corporation
TEAR
| $271K | 0.28% |
209,973
-15,616
| -7% | -$27.6K |
|
|
BKYI
73
BIO-key International
BKYI
$4.2M
| $265K | 0.28% |
+64
| New | +$294K |
|
74
Apple
AAPL
$4.99T
| $250K | 0.26% |
6,500
-2,980
| -31% | -$116K |
|
|
CTG
75
DELISTED
Computer Task Group, Inc.
CTG
| $244K | 0.26% |
45,500
+1,700
| +4% | +$9.12K |
|
Similar funds
SVP
PWP
BF
SFG
HWMG
CAG
FTEA
WT
Perkins Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Perkins Capital Management held 118 positions worth $95.4M, up 5.9% from $90.2M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Perkins Capital Management withdrew a net $3.93M in Q3 2017, closing 16 positions and reducing 46 holdings. Its most notable exit was JetBlue, an estimated $1.05M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Bristol-Myers Squibb worth $1.12M.
- Perkins Capital Management's largest Q3 2017 buy was Bristol-Myers Squibb: 17,525 shares worth $1.12M.
- Perkins Capital Management added most to Vericel Corp in Q3 2017, an estimated $1.17M increase.
- Perkins Capital Management's biggest Q3 2017 reduction was CryoPort, cutting an estimated $1.36M.
- Perkins Capital Management fully exited JetBlue in Q3 2017, selling an estimated $1.05M.
- Perkins Capital Management's ten largest holdings make up 39% of its $95.4M portfolio in Q3 2017.
- Perkins Capital Management opened 12 new positions and closed 16 in Q3 2017.
- Perkins Capital Management's portfolio value rose 5.9% quarter-over-quarter to $95.4M.
Based on Perkins Capital Management's 13F filing for Q3 2017, filed 31 Oct 2017.